ArticleActa pharmacologica Sinica2023

p52-ZER6: a determinant of tumor cell sensitivity to MDM2-p53 binding inhibitors.

Wen-Fang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.